Expand ADIL Menu
ADIL MENU

ADIL Latest Press Releases

-- June 16, 2026 --

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing Globe Newswire 8:00 AM

-- June 11, 2026 --

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing Globe Newswire 11:43 AM

-- May 11, 2026 --

Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update Globe Newswire 8:30 AM

-- April 29, 2026 --

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045 Globe Newswire 9:07 AM

-- April 27, 2026 --

Adial Pharmaceuticals Submits Application to FDA Commissioner's National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program Globe Newswire 8:47 AM

-- April 22, 2026 --

Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial Globe Newswire 9:35 AM

-- March 24, 2026 --

Adial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans Globe Newswire 9:07 AM

-- March 6, 2026 --

Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update Globe Newswire 8:00 AM

-- March 3, 2026 --

Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of a Definitive Agreement Globe Newswire 8:17 AM

-- February 24, 2026 --

Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement Globe Newswire 9:00 AM

-- February 23, 2026 --

Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One Globe Newswire 8:30 AM

-- February 17, 2026 --

Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 9:00 AM

-- February 4, 2026 --

Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 Globe Newswire 9:35 AM

-- February 3, 2026 --

Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes